Document is current
Any future updates will be listed below
-
Authors
Cheon, Jaekyung
Shimose, Shigeo
Kim, Hyung-Don
Niizeki, Takashi
Ryu, Min-Hee
Shirono, Tomotake
Ryoo, Baek-Yeol
Iwamoto, Hideki
Yoo, Changhoon
- License Information
-
More Information
Article History
Received: 25 November 2024
Accepted: 6 January 2025
First Online: 28 January 2025
Declarations
:
: This study was conducted in compliance with the Declaration of Helsinki and Good Clinical Practice guidelines. All study protocols were reviewed and approved by the institutional review boards of each participating center (Asan Medical Center, 2021-0064; Kurume University School of Medicine; 23006). Academic investigators were responsible for the study design. The requirement for informed consent from enrolled patients was waived owing to the retrospective nature of the study.
: J. Cheon received honoraria from Eisai, and Roche, and received research grants from Bayer. C. Yoo received honoraria from Servier, Bayer, AstraZeneca, Merck Sharp & Dohme, Eisai, Celgene, Bristol Myers Squibb, Ipsen, Novartis, Boryung, Mundipharma, and Roche, and received research grants from Servier, Bayer, AstraZeneca, Ono Pharmaceuticals, Ipsen, Boryung and Lunit Inc. All other authors declare no competing interests.
